Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Other Publications
    • ajnr

User menu

  • Subscribe
  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

  • Subscribe
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds
Research ArticleBrain

Apparent Diffusion Coefficient Histogram Analysis Stratifies Progression-Free Survival in Newly Diagnosed Bevacizumab-Treated Glioblastoma

W.B. Pope, A. Lai, R. Mehta, H.J. Kim, J. Qiao, J.R. Young, X. Xue, J. Goldin, M.S. Brown, P.L. Nghiemphu, A. Tran and T.F. Cloughesy
American Journal of Neuroradiology May 2011, 32 (5) 882-889; DOI: https://doi.org/10.3174/ajnr.A2385
W.B. Pope
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Lai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Mehta
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H.J. Kim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Qiao
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J.R. Young
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
X. Xue
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Goldin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M.S. Brown
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P.L. Nghiemphu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Tran
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T.F. Cloughesy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Information

vol. 32 no. 5 882-889
DOI 
https://doi.org/10.3174/ajnr.A2385
PubMed 
21330401

Published By 
American Journal of Neuroradiology
Print ISSN 
0195-6108
Online ISSN 
1936-959X
History 
  • Received July 15, 2010
  • Accepted after revision September 9, 2010
  • Published online May 13, 2011.

Article Versions

  • Latest version (February 17, 2011 - 06:53).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © American Society of Neuroradiology

Author Information

  1. W.B. Popea,
  2. A. Laib,
  3. R. Mehtaa,
  4. H.J. Kima,
  5. J. Qiaoa,
  6. J.R. Younga,
  7. X. Xuea,
  8. J. Goldina,
  9. M.S. Browna,
  10. P.L. Nghiemphub,
  11. A. Tranb and
  12. T.F. Cloughesyb
  1. aFrom the Departments of Radiological Sciences (W.B.P., R.M., H.J.K., J.Q., J.R.Y., X.X., J.G., M.S.B.)
  2. bNeurology (A.L., P.L.N., A.T., T.F.C.), David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California.
  1. Please address correspondence to Whitney B. Pope, MD, PhD, Department of Radiological Sciences, David Geffen School of Medicine at UCLA, 10833 Le Conte Ave, BL-428 CHS, Los Angeles, CA 90095-1721; e-mail: wpope{at}mednet.ucla.edu
View Full Text

Altmetrics

Cited By...

  • 121 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 32 (5)
American Journal of Neuroradiology
Vol. 32, Issue 5
1 May 2011
  • Table of Contents
  • Index by author
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Apparent Diffusion Coefficient Histogram Analysis Stratifies Progression-Free Survival in Newly Diagnosed Bevacizumab-Treated Glioblastoma
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Apparent Diffusion Coefficient Histogram Analysis Stratifies Progression-Free Survival in Newly Diagnosed Bevacizumab-Treated Glioblastoma
W.B. Pope, A. Lai, R. Mehta, H.J. Kim, J. Qiao, J.R. Young, X. Xue, J. Goldin, M.S. Brown, P.L. Nghiemphu, A. Tran, T.F. Cloughesy
American Journal of Neuroradiology May 2011, 32 (5) 882-889; DOI: 10.3174/ajnr.A2385

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Apparent Diffusion Coefficient Histogram Analysis Stratifies Progression-Free Survival in Newly Diagnosed Bevacizumab-Treated Glioblastoma
W.B. Pope, A. Lai, R. Mehta, H.J. Kim, J. Qiao, J.R. Young, X. Xue, J. Goldin, M.S. Brown, P.L. Nghiemphu, A. Tran, T.F. Cloughesy
American Journal of Neuroradiology May 2011, 32 (5) 882-889; DOI: 10.3174/ajnr.A2385
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Abstract
    • Abbreviations
    • Materials and Methods
    • Results
    • Discussion
    • Conclusions
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Diffusion Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3-K27M Mutation Using Apparent Diffusion Coefficient Histogram Analysis
  • Prognostic Implications of Gadolinium Enhancement of Skull Base Chordomas
  • Correlation of 18F-FDG PET and MRI Apparent Diffusion Coefficient Histogram Metrics with Survival in Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium
  • ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI
  • Differentiating Tumor Progression from Pseudoprogression in Patients with Glioblastomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI
  • The Added Prognostic Value of Preoperative Dynamic Contrast-Enhanced MRI Histogram Analysis in Patients with Glioblastoma: Analysis of Overall and Progression-Free Survival
  • Lessons From Anti-Vascular Endothelial Growth Factor and Anti-Vascular Endothelial Growth Factor Receptor Trials in Patients With Glioblastoma
  • Phase II Study of Bevacizumab, Temozolomide, and Hypofractionated Stereotactic Radiotherapy for Newly Diagnosed Glioblastoma
  • Diffusion-Weighted Imaging in Cancer: Physical Foundations and Applications of Restriction Spectrum Imaging
  • A Prognostic Model Based on Preoperative MRI Predicts Overall Survival in Patients with Diffuse Gliomas
  • Pretreatment ADC Histogram Analysis Is a Predictive Imaging Biomarker for Bevacizumab Treatment but Not Chemotherapy in Recurrent Glioblastoma
  • Diffusion-Weighted MR Imaging and MGMT Methylation Status in Glioblastoma: A Reappraisal of the Role of Preoperative Quantitative ADC Measurements
  • Do Imaging Biomarkers Relate to Outcome in Patients Treated with VEGF Inhibitors?
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • Evaluating the Effects of White Matter Multiple Sclerosis Lesions on the Volume Estimation of 6 Brain Tissue Segmentation Methods
  • Quiet PROPELLER MRI Techniques Match the Quality of Conventional PROPELLER Brain Imaging Techniques
  • Predictors of Reperfusion in Patients with Acute Ischemic Stroke
Show more BRAIN

Similar Articles

Advertisement

News and Updates

  • Lucien Levy Best Research Article Award
  • Thanks to our 2020 Distinguished Reviewers
  • Press Releases

Resources

  • Evidence-Based Medicine Level Guide
  • How to Participate in a Tweet Chat
  • AJNR Podcast Archive
  • Ideas for Publicizing Your Research
  • Librarian Resources
  • Terms and Conditions

Opportunities

  • Share Your Art in Perspectives
  • Get Peer Review Credit from Publons
  • Moderate a Tweet Chat

American Society of Neuroradiology

  • Neurographics
  • ASNR Annual Meeting
  • Fellowship Portal
  • Position Statements

© 2021 by the American Society of Neuroradiology | Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire